The headline this quarter: AI's industrialisation is well underway, but the gap between what models can do and what enterprises actually deploy keeps widening. Capability accelerated roughly 2x in 2024, driven not just by raw compute but by new paradigms: reinforcement learning,… continue reading

The field crossed a critical threshold in June 2025: the first peer-reviewed Phase IIa results for a molecule where both target and compound were discovered entirely by generative AI. Insilico Medicine's rentosertib, a TNIK inhibitor for idiopathic pulmonary fibrosis, showed… continue reading

The crop protection market is undergoing a compulsory transformation. On one side, EU regulations increasingly cap active ingredient volumes per hectare (Regulation (EC) No 1107/2009), and farmers legally cannot apply more, even if crops need it. On the other, the bioactive… continue reading